Bepotastine
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Bepotastine
Description :
Bepotastine is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF) . Bepotastine has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research[1][2][3][4].CAS Number :
[125602-71-3]UNSPSC :
12352005Hazard Statement :
H302, H312, H332Target :
Histamine ReceptorType :
Reference compoundRelated Pathways :
GPCR/G Protein; Immunology/Inflammation; Neuronal SignalingApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Endocrinology; Inflammation/ImmunologyAssay Protocol :
https://www.medchemexpress.com/bepotastine.htmlPurity :
98.58Solubility :
DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mLSmiles :
O=C(O)CCCN1CCC(O[C@@H](C2=CC=C(Cl)C=C2)C3=CC=CC=N3)CC1Molecular Formula :
C21H25ClN2O3Molecular Weight :
388.89Precautions :
H302, H312, H332References & Citations :
[1]Jon I Williams, et al. Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate. Curr Med Res Opin. 2010 Oct;26 (10) :2329-38.|[2]Kida T, et al. Bepotastine besilate, a highly selective histamine H (1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. Exp Eye Res. 2010 Jul;91 (1) :85-91. |[3]Tanizaki H, et al. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice. Int Arch Allergy Immunol. 2008;145 (4) :277-82.|[4]Kamata Y, et al. Bepotastine besilate downregulates the expression of nerve elongation factors in normal human epidermal keratinocytes. J Dermatol Sci. 2018 Apr 23:S0923-1811 (18) 30186-5.Shipping Conditions :
Room TemperatureStorage Conditions :
4°C (Powder, sealed storage, away from moisture)Scientific Category :
Reference compound1Clinical Information :
LaunchedIsoform :
H1 Receptor

